"1. Introduction
... [B]illions of people were vaccinated despite a paucity of data regarding biodistribution or bio-persistence in humans, which only emerged from independent research or Freedom of Information disclosures after the administration of billions of doses. The speed at which the genetic vaccines were developed, manufactured and released was presented to the public as an achievement made possible by the scientific prowess of the pharmaceutical industry working in partnership with global governments for the greater good. However, in the words of the recently retired head of vaccine R&D at Pfizer, Dr. Kathrin Jansen: 'We flew the aeroplane while we were still building it'. This 'achievement' involved scientific imprudence that must be subject to increased scrutiny as evidence of safety signals, negative vaccine efficacy and immune escape continues to accumulate.
The rationale behind this review article is to address the critical issue of the off-target distribution exhibited by the genetic vaccines against COVID-19, with a particular focus on the immunohistochemistry findings from histopathological studies...
7. Conclusions
Numerous studies report the onset of autoimmune reactions following COVID-19 vaccination. The histopathological data provide indisputable evidence that demonstrates that the genetic vaccines exhibit an off-target distribution, causing the synthesis of the spike protein and thus triggering autoimmune inflammatory reactions, even in tissues which are terminally differentiated and subject to symptomatic damage. Despite the fact that the mechanisms of the antigen processing and presentation and the consequences for cells synthesising viral proteins are largely known and have been characterised for decades, the genetic vaccines were rolled out in the absence of accurate biodistribution and bio-persistence evaluations in humans, and the vast majority of the scientific community accepted that without raising concerns. Indeed, page 20 of Pfizer’s non-clinical overview submitted to FDA in 2021 stated: 'No RNA or protein metabolism or excretion studies will be conducted'...
Moreover, the guidance against performing autopsies, ostensibly to limit viral transmission, implemented by many countries worldwide during the pandemic, severely limited the ability to gather more clinical information regarding direct evidence of injuries in tissues which may have led to vaccine-related deaths. The association of COVID-19 vaccination with the development of serious cardiovascular complications, especially amongst the younger and healthier age groups, has been widely recognised... In conclusion, in light of the undeniable evidence of off-target distribution, the administration of genetic vaccines against COVID-19 should be halted until accurate pharmacokinetic, pharmacodynamic and genotoxicity studies are performed, or they should only be delivered in circumstances when the benefits greatly outweigh the risks."
This is an open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.